NCT06530771

Brief Summary

The goal of this clinical trial is to explore the value of a multimodal ultrasound model based on Angio Planewave Ultrasensitive Imaging, Shear Wave Elastography and grayscale ultrasound in the differential diagnosis of benign and malignant thyroid nodules. The main questions it aims to answer are: Can an innovative ultra-microvascular classification system based on Angio Planewave Ultrasensitive Imaging distinguish between benign and malignant thyroid nodules? How about the performance of multimodal ultrasound model to Guide the Fine-Needle Aspiration Management of Thyroid Lesions? Participants will: Undergo grayscale ultrasound, SWE, and Angio Planewave Ultrasensitive Imaging multimodal thyroid ultrasound examination within one week before surgery Undergo surgery and obtain the postoperative pathological diagnosis

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
720

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

July 29, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 31, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

July 31, 2024

Status Verified

December 1, 2023

Enrollment Period

2.4 years

First QC Date

July 29, 2024

Last Update Submit

July 30, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Diagnostic efficacy

    the area under the receiver operating characteristic (ROC) curve (AUC)

    one week

  • Diagnostic efficacy

    sensitivity, specificity, accuracy

    one week

  • positive predictive value (PPV), and negative predictive value (NPV)

    Diagnostic efficacy

    one week

Study Arms (2)

Malignant thyroid nodules

Diagnostic Test: ultrasound

Benign thyroid nodules

Diagnostic Test: ultrasound

Interventions

ultrasoundDIAGNOSTIC_TEST

Conventional US, SWE, and AP of thyroid nodules were conducted successively with a Supersonic Aixplorer system (SuperSonic Imagine, Aix-en-Provence, France) using a 5-14 MHz linear transducer.

Benign thyroid nodulesMalignant thyroid nodules

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Population data for this prospective single-center cohort study were gathered at the Fifth Affiliated Hospital of Sun Yat-sen University.

You may qualify if:

  • age more than 18 years;
  • Voluntarily signed informed consent;
  • Have 1 or more thyroid nodules detectable by ultrasound;
  • participant underwent surgical procedure to confirm the pathologic results

You may not qualify if:

  • Nodules are accompanied by large calcifications followed by acoustic shadows
  • History of previous neck surgery or cancer, thyroid medications, radiation or surgical treatment;
  • Poor quality of retained images or non-standard operations (such as intermittent scanning and improper probe compression), and incomplete pathological results.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Fifth Affiliated Hospital Sun Yat-Sen University

Zhuhai, Guangdong, 519000, China

RECRUITING

MeSH Terms

Conditions

Thyroid Neoplasms

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2024

First Posted

July 31, 2024

Study Start

July 1, 2022

Primary Completion

November 30, 2024

Study Completion

December 30, 2024

Last Updated

July 31, 2024

Record last verified: 2023-12

Locations